Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA. [PDF]
Oncotarget, 2018 Background MicroRNAs biomarkers have shown value for diagnosis and prognosis of various cancers. Combination with established tumor markers has rarely been done.
Zaleski M +9 more
europepmc +2 more sources
Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes. [PDF]
PLoS One, 2018 This work presents an alternative device for cancer screening in liquid biopsies. It combines a biomimetic film (i) with electrochemical detection (ii). The biomimetic film (i) was obtained by electro-polymerizing amine-substituted benzene rings around a
Gomes RS +3 more
europepmc +2 more sources
CA 15 − 3 may be a promising biomarker for differentiating distant organ metastasis in breast cancer at initial diagnosis [PDF]
BMC CancerBackground Imaging techniques for breast cancer identify distant organ metastasis, but can be time-consuming and costly. This study compares clinicopathological and laboratory data between metastatic and nonmetastatic breast cancer patients at initial ...
Serkan Yilmaz, Mesut Yur
doaj +2 more sources
Antibody Biomimetic Material Made of Pyrrole for CA 15-3 and Its Application as Sensing Material in Ion-Selective Electrodes for Potentiometric Detection. [PDF]
Biosensors (Basel), 2018 This work reports a very simple approach for creating a synthetic antibody against any protein of interest and its application in potentiometric transduction.
Santos ART +3 more
europepmc +2 more sources
CA 15–3: A Prognostic Marker in Breast Cancer
The International Journal of Biological Markers, 2000 CA 15–3 (also known as MUC1) is the most widely used serum marker in breast cancer. MUC1 is a large transmembrane glycoprotein which is frequently overexpressed and aberrantly glycosylated in cancer.
M.J. Duffy +4 more
doaj +3 more sources
Electrochemical immunosensor for detection of CA 15-3 biomarker in point-of-care
Sensing and Bio-Sensing Research, 2021 This work reports the development of a simple and rapid electrochemical immunosensor for the determination of breast cancer biomarker Cancer Antigen 15–3 (CA 15–3). Disposable and cost-effective chips, consisting of gold screen-printed electrodes (AuSPEs)
Tânia S.C.R. Rebelo +3 more
doaj +2 more sources
Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy. [PDF]
J Clin Med Res, 2017 Background The aim of the study was to explore the prognostic impact of different abnormal blood tests and the tumor marker CA 15-3 as well as established parameters such as disease extent and receptor status in patients with bone metastases from breast ...
Nieder C +4 more
europepmc +2 more sources
Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer. [PDF]
Mol Clin Oncol, 2015 The objective of this study was to investigate the association of serum cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) levels with clinicopathological parameters in patients diagnosed with metastatic breast cancer (MBC).
Geng B, Liang MM, Ye XB, Zhao WY.
europepmc +2 more sources
J Midlife Health, 2018 Objective: This study aims to determine the association of dyslipidemia and increased insulin resistance (IR) with increased breast cancer (BC) risk. Materials and Methods: The study group comprised 110 premenopausal and 143 postmenopausal, untreated ...
Kachhawa P +5 more
europepmc +2 more sources
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients. [PDF]
BMC Cancer, 2016 BackgroundMetastatic breast cancer (MBC) prognosis is highly variable, depending on various factors such as the biological subtype, the performance status, disease extension….
Darlix A +7 more
europepmc +2 more sources